← Evidence map

ArticleFrontiers in pharmacology2023

Inhibition of PPARγ by BZ26, a GW9662 derivate, attenuated obesity-related breast cancer progression by inhibiting the reprogramming of mature adipocytes into to cancer associate adipocyte-like cells.

Liangge Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

6 papers cite it

2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 37649895